• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin M Increased Creatine Kinase May Predict A Worse COVID-19 Outcome

tetano

Editor, Senior Moderator
J Clin Med


. 2021 Apr 16;10(8):1734.
doi: 10.3390/jcm10081734.
Increased Creatine Kinase May Predict A Worse COVID-19 Outcome


Daniele Orsucci[SUP] 1 2 [/SUP], Michele Trezzi[SUP] 3 [/SUP], Roberto Anichini[SUP] 4 [/SUP], Pierluigi Blanc[SUP] 3 [/SUP], Leandro Barontini[SUP] 5 [/SUP], Carlo Biagini[SUP] 6 [/SUP], Alessandro Capitanini[SUP] 7 [/SUP], Marco Comeglio[SUP] 8 [/SUP], Paulo Corsini[SUP] 9 [/SUP], Federico Gemignani[SUP] 10 [/SUP], Roberto Giannecchini[SUP] 9 [/SUP], Massimo Giusti[SUP] 10 [/SUP], Mario Lombardi[SUP] 11 [/SUP], Elena Marrucci[SUP] 10 [/SUP], Alessandro Natali[SUP] 11 [/SUP], Gabriele Nenci[SUP] 10 [/SUP], Franco Vannucci[SUP] 12 [/SUP], Gino Volpi[SUP] 1 [/SUP]



Affiliations

Abstract

Early reports from Asia suggested that increased serum levels of the muscular enzyme creatine-(phospho)-kinase (CK/CPK) could be associated with a more severe prognosis in COVID-19. The aim of this single-center retrospective cohort study of 331 consecutive COVID-19 patients who were hospitalized during Italy's "first wave" was to verify this relationship, and to evaluate the role of possible confounding factors (age, body mass index, gender, and comorbidities). We subdivided our cohort in two groups, based on "severe" (n = 99) or "mild" (n = 232) outcomes. "Severe" disease is defined here as death and/or mechanical invasive ventilation, in contrast to "mild" patients, who were discharged alive with no need for invasive ventilation; this latter group could also include those patients who were treated with non-invasive ventilation. The CK levels at admission were higher in those subjects who later experienced more severe outcomes (median, 126; range, 10-1672 U/L, versus median, 82; range, 12-1499 U/L, p = 0.01), and hyperCKemia >200 U/L was associated with a worse prognosis. Regression analysis confirmed that increased CK acted as an independent predictor for a "severe" outcome. HyperCKemia was generally transient, returning to normal during hospitalization in the majority of both "severe" and "mild" patients. Although the direct infection of voluntary muscle is unproven, transient muscular dysfunction is common during the course of COVID-19. The influence of this novel coronavirus on voluntary muscle really needs to be clarified.

Keywords: CK; CPK; SARS-CoV-2; coronavirus; myopathy.
 
Back
Top Bottom